FindTrial
Sign In

A Study to evaluate the efficacy of yogaraja guggulu in Dyslipidemia (Medoroga).

A Randomized open labelled controlled clinical study to evaluate the efficacy of Yogaraja guggulu in the management of Medoroga with special reference to Dyslipidemia. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070818
Enrollment
30
Registered
2024-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Sponsors

Dr Krishna sai P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Subjects of either gender between the age group of 21-60 years. • Subjects who full fill the diagnostic criteria. • Both obese and non obese subjects will be included. • Subjects willing to participate with written informed consent, which is conveyed in the language, which the subject can understand. • Subjects with only Grade 1 & Grade 2 Dyslipidemia would be taken .

Exclusion criteria

Exclusion criteria: • Subjects who are on any medication for Dyslipidemia. • Subjects with any uncontrolled systemic illness like Diabetes Mellitus, Hypertension • Pregnant and Lactating women

Design outcomes

Primary

MeasureTime frame
Changes in Serum Lipid profileTimepoint: before intervention- 0th day after intervention- 30th day follow up- 45th day—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Sowmyashree U P

Sri Sri College of Ayurvedic Science and Research Hospital, Bangalore

upsprasad@gmail.com9743893056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026